Psychedelics, Transformative Experiences and Healing: An Interview with Katrina Michelle
Katrina Michelle is a psychologist and the founder and director of The Curious Spirit, a transpersonally oriented psychotherapeutic practice that encourages transcendent personal exploration to remedy psychological suffering. She is a holistic psychotherapist currently serving as faculty at Columbia University School of Social Work and The Institute for the Development of Human Arts.
In addition to her practice, she also serves as the director of harm reduction for the Multidisciplinary Association for Psychedelic Studies (MAPS) and formerly worked as the executive director of the American Center for the Integration of Spiritually Transformative Experiences (ACISTE). To demystify awakening experiences through storytelling and art, she is also producing the film
Scientific American
The illegal substance paired with intensive therapy and hard work dramatically improves PTSD symptoms
Advertisement
A long-awaited study is making worldwide headlines for finding that the outlawed psychoactive drug MDMA is startlingly effective in treating post-traumatic stress disorder (PTSD). But researchers and study participants say the substance itself, while extremely powerful, catalyzes healing rather than working on its own: MDMA treatment also requires dozens of hours of therapy before, during and after the drug experience with professionals whose special training is expensive and intense.
Researchers hope the new study, published this week in
Nature Medicine, will help this treatment gain regulators’ approval for clinical use within a couple of years. Many therapists and patients are thrilled: About two thirds of PTSD sufferers do not respond to other treatments. And MDMA had shown tremendous promise in earlier, smaller studies.
11 MAY 2021
MDMA may mostly be known as an illicit party drug, but this psychoactive chemical looks to offer therapeutic applications far removed from the highs of the rave scene.
In fact, MDMA-assisted therapy could soon become a legal and approved way to treat post-traumatic stress disorder (PTSD) in the United States.
In the first phase III clinical trial for any psychedelic-assisted therapy, MDMA has shown more potential to help treat PTSD with therapy than possibly any other medicine we ve got.
After just three sessions, patients who were given MDMA during therapy were 35 percent less likely to meet the diagnosis for PTSD than those given a placebo.
NA Proactive news snapshot: Fortitude Gold, BlueRush, Sassy Resources, Organic Garage, Alpine 4 Holdings, Lucky Minerals UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Fortitude Gold Corp (OTCQB:FTCO) announced the timing of its first quarter 2021 earnings conference call scheduled for Wednesday, May 12, 2021. CEO Jason Reid will host the conference call at 11:00 AM ET. Topics of discussion will include first quarter results and an update on current operations. The conference call will be recorded and posted to the company s website. To join the conference via webcast, please click on the following link: https://www.webcaster4.com/Webcast/Page/2640/41269. To join the call via telephone please use one of the following dial-in details: Toll Free: 877-407-8031 or International: 201-689-8031.
NA Proactive news snapshot: Fortitude Gold, BlueRush, Sassy Resources, Organic Garage, Alpine 4 Holdings, Lucky Minerals UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Fortitude Gold Corp (OTCQB:FTCO) announced the timing of its first quarter 2021 earnings conference call scheduled for Wednesday, May 12, 2021. CEO Jason Reid will host the conference call at 11:00 AM ET. Topics of discussion will include first quarter results and an update on current operations. The conference call will be recorded and posted to the company s website. To join the conference via webcast, please click on the following link: https://www.webcaster4.com/Webcast/Page/2640/41269. To join the call via telephone please use one of the following dial-in details: Toll Free: 877-407-8031 or International: 201-689-8031.